OSM May Serve as a Biomarker of Poor Prognosis in Clear Cell Renal Cell Carcinoma and Promote Tumor Cell Invasion and Migration
Background. Currently, the role of oncostatin M (OSM) in clear cell renal cell carcinoma (ccRCC) has not been investigated. This study will explore the impact of OSM on ccRCC expression, prognosis, and cell function. Materials and Methods. In this study, we used The Cancer Genome Atlas (TCGA) databa...
Saved in:
Main Authors: | Shuzhang Wei, Yin Chen, Xiaokai Shi, Li Zuo, Lifeng Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | International Journal of Genomics |
Online Access: | http://dx.doi.org/10.1155/2023/6665452 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Upregulated GSDMB in Clear Cell Renal Cell Carcinoma Is Associated with Immune Infiltrates and Poor Prognosis
by: Yuanshan Cui, et al.
Published: (2021-01-01) -
Identification of RAGE and OSM as New Prognosis Biomarkers of Severe Pneumonia
by: Jing Lei, et al.
Published: (2022-01-01) -
PSRC1 could serve as a prognostic biomarker for patients with renal clear-cell carcinoma
by: Renlong Zhou, et al.
Published: (2025-02-01) -
The increased ANXA5 expression indicates poor prognosis in renal clear cell carcinoma
by: Lingxiang Ran, et al.
Published: (2025-02-01) -
Downregulation of FXYD2 Is Associated with Poor Prognosis and Increased Regulatory T Cell Infiltration in Clear Cell Renal Cell Carcinoma
by: Zedan Zhang, et al.
Published: (2022-01-01)